Join
Live feed
·
INSIDERFilingvia Quantisnow
Abeona Therapeutics Inc. logo

Director Alvino Mark sold $71,168 worth of shares (15,000 units at $4.74), decreasing direct ownership by 19% to 62,252 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ABEO· Abeona Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABEO (Abeona Therapeutics Inc.) and more on Quantisnow.